Patents by Inventor Lakkaraju Dasaradhi

Lakkaraju Dasaradhi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Solid compositions and methods for generating chlorine dioxide
    Patent number: 9834443
    Abstract: A composition for generating chlorine dioxide comprises active ingredients, a suitable hydrophobic compound, and a suitable super absorbent compound. A suitable hydrophobic compound will, among other characteristics, repel the solvent for at least the initial 30 seconds of exposure thereto. A suitable super absorbent compound will, among other characteristics, absorb at least 75 times its weight in solvent and will not gel until the chlorine-dioxide generating reaction is substantially complete.
    Type: Grant
    Filed: September 23, 2013
    Date of Patent: December 5, 2017
    Assignee: Sipka, Inc.
    Inventors: John Appadurai Thangaraj, Lakkaraju Dasaradhi
  • Stable bortezomib formulations
    Patent number: 9180093
    Abstract: Multi-dose formulations for bortezomib are presented in which bortezomib has significantly improved stability. Especially preferred formulations include those in which bortezomib is in a liquid form suitable for injection, wherein the solvent system predominantly comprises propylene glycol. In other preferred aspects, bortezomib is present as a Lewis donor-acceptor complex with a hetero-bifunctional Lewis base.
    Type: Grant
    Filed: August 22, 2012
    Date of Patent: November 10, 2015
    Assignee: Innopharma, Inc.
    Inventors: Kumaresh Soppimath, Satish Pejaver, Kanaiyalal R. Patel, Lakkaraju Dasaradhi, Rama Sodum, Hari Desu, Navneet Puri
  • Stable bortezomib formulations
    Patent number: 9107821
    Abstract: Multi-dose formulations for bortezomib are presented in which bortezomib has significantly improved stability. Especially preferred formulations include those in which bortezomib is in a liquid form suitable for injection, wherein the solvent system predominantly comprises propylene glycol. In other preferred aspects, bortezomib is present as a Lewis donor-acceptor complex with a hetero-bifunctional Lewis base.
    Type: Grant
    Filed: August 22, 2012
    Date of Patent: August 18, 2015
    Assignee: Innopharma, Inc.
    Inventors: Kumaresh Soppimath, Satish Pejaver, Kanaiyalal R. Patel, Lakkaraju Dasaradhi, Rama Sodum, Hari Desu, Navneet Puri
  • Stable bortezomib formulations
    Patent number: 9061037
    Abstract: Multi-dose formulations for bortezomib are presented in which bortezomib has significantly improved stability. Especially preferred formulations include those in which bortezomib is in a liquid form suitable for injection, wherein the solvent system predominantly comprises propylene glycol. In other preferred aspects, bortezomib is present as a Lewis donor-acceptor complex with a hetero-bifunctional Lewis base.
    Type: Grant
    Filed: March 18, 2011
    Date of Patent: June 23, 2015
    Assignee: Innopharma, Inc.
    Inventors: Kumaresh Soppimath, Satish Pejaver, Kanaiyalal R. Patel, Lakkaraju Dasaradhi, Rama Sodum, Hari Desu, Navneet Puri
  • SOLID COMPOSITIONS AND METHODS FOR GENERATING CHLORINE DIOXIDE
    Publication number: 20150083963
    Abstract: A composition for generating chlorine dioxide comprises active ingredients, a suitable hydrophobic compound, and a suitable super absorbent compound. A suitable hydrophobic compound will, among other characteristics, repel the solvent for at least the initial 30 seconds of exposure thereto. A suitable super absorbent compound will, among other characteristics, absorb at least 75 times its weight in solvent and will not gel until the chlorine-dioxide generating reaction is substantially complete.
    Type: Application
    Filed: September 23, 2013
    Publication date: March 26, 2015
    Applicant: Sipka Inc.
    Inventors: John Appadurai Thangaraj, Lakkaraju Dasaradhi
  • Solid compositions and methods for generating chlorine dioxide
    Patent number: 8540895
    Abstract: A composition for generating chlorine dioxide comprises active ingredients, a suitable hydrophobic compound, and a suitable super absorbent compound. A suitable hydrophobic compound will, among other characteristics, repel the solvent for at least the initial 30 seconds of exposure thereto. A suitable super absorbent compound will, among other characteristics, absorb at least 75 times its weight in solvent and will not gel until the chlorine-dioxide generating reaction is substantially complete.
    Type: Grant
    Filed: July 6, 2011
    Date of Patent: September 24, 2013
    Assignee: Sipka Inc.
    Inventors: John Appadurai Thangaraj, Lakkaraju Dasaradhi
  • Stable Bortezomib Formulations
    Publication number: 20120322762
    Abstract: Multi-dose formulations for bortezomib are presented in which bortezomib has significantly improved stability. Especially preferred formulations include those in which bortezomib is in a liquid form suitable for injection, wherein the solvent system predominantly comprises propylene glycol. In other preferred aspects, bortezomib is present as a Lewis donor-acceptor complex with a hetero-bifunctional Lewis base.
    Type: Application
    Filed: August 22, 2012
    Publication date: December 20, 2012
    Applicant: INNOPHARMA, INC.
    Inventors: Kumaresh Soppimath, Satish Pejaver, Kanaiyalal R. Patel, Lakkaraju Dasaradhi, Rama Sodum, Hari Desu, Navneet Puri
  • Stable Bortezomib Formulations
    Publication number: 20120322763
    Abstract: Multi-dose formulations for bortezomib are presented in which bortezomib has significantly improved stability. Especially preferred formulations include those in which bortezomib is in a liquid form suitable for injection, wherein the solvent system predominantly comprises propylene glycol. In other preferred aspects, bortezomib is present as a Lewis donor-acceptor complex with a hetero-bifunctional Lewis base.
    Type: Application
    Filed: August 22, 2012
    Publication date: December 20, 2012
    Applicant: INNOPHARMA, INC.
    Inventors: Kumaresh Soppimath, Satish Pejaver, Kanaiyalal R. Patel, Lakkaraju Dasaradhi, Rama Sodum, Hari Desu, Navneet Puri
  • Stable bortezomib formulations
    Patent number: 8263578
    Abstract: Multi-dose formulations for bortezomib are presented in which bortezomib has significantly improved stability. Especially preferred formulations include those in which bortezomib is in a liquid form suitable for injection, wherein the solvent system predominantly comprises propylene glycol. In other preferred aspects, bortezomib is present as a Lewis donor-acceptor complex with a hetero-bifunctional Lewis base.
    Type: Grant
    Filed: March 27, 2012
    Date of Patent: September 11, 2012
    Assignee: InnoPharma, Inc.
    Inventors: Kumaresh Soppimath, Satish Pejaver, Kanaiyalal R. Patel, Lakkaraju Dasaradhi, Rama Sodum, Hari Desu, Navneet Puri
  • Stable Bortezomib Formulations
    Publication number: 20120172808
    Abstract: Multi-dose formulations for bortezomib are presented in which bortezomib has significantly improved stability. Especially preferred formulations include those in which bortezomib is in a liquid form suitable for injection, wherein the solvent system predominantly comprises propylene glycol. In other preferred aspects, bortezomib is present as a Lewis donor-acceptor complex with a hetero-bifunctional Lewis base.
    Type: Application
    Filed: March 27, 2012
    Publication date: July 5, 2012
    Applicant: INNOPHARMA, LLC
    Inventors: Kumaresh Soppimath, Satish Pejaver, Kanaiyalal R. Patel, Lakkaraju Dasaradhi, Rama Sodum, Hari Desu, Navneet Puri
  • Solid Compositions and Methods for Generating Chlorine Dioxide
    Publication number: 20110309297
    Abstract: A composition for generating chlorine dioxide comprises active ingredients, a suitable hydrophobic compound, and a suitable super absorbent compound. A suitable hydrophobic compound will, among other characteristics, repel the solvent for at least the initial 30 seconds of exposure thereto. A suitable super absorbent compound will, among other characteristics, absorb at least 75 times its weight in solvent and will not gel until the chlorine-dioxide generating reaction is substantially complete.
    Type: Application
    Filed: July 6, 2011
    Publication date: December 22, 2011
    Applicant: SIPKA INC.
    Inventors: John Appadurai Thangaraj, Lakkaraju Dasaradhi
  • STABLE BORTEZOMIB FORMULATIONS
    Publication number: 20110230441
    Abstract: Multi-dose formulations for bortezomib are presented in which bortezomib has significantly improved stability. Especially preferred formulations include those in which bortezomib is in a liquid form suitable for injection, wherein the solvent system predominantly comprises propylene glycol. In other preferred aspects, bortezomib is present as a Lewis donor-acceptor complex with a hetero-bifunctional Lewis base.
    Type: Application
    Filed: March 18, 2011
    Publication date: September 22, 2011
    Applicant: INNOPHARMA, LLC
    Inventors: Kumaresh Soppimath, Satish Pejaver, Kanaiyalal R. Patel, Lakkaraju Dasaradhi, Rama Sodum, Hari Desu, Navneet Puri
  • Methods and Solid Compositions for Generating Soapy and Non-Soapy Aqueous Solutions Containing Free Chlorine Dioxide
    Publication number: 20080067470
    Abstract: Some embodiments of the invention provide solid compositions that, when exposed to or otherwise placed in an aqueous solution, will release chlorine dioxide and surfactants, producing a soapy, aqueous solution containing chlorine dioxide. These solid compositions comprise an alkali chlorite salt, a solid acid source, and a surfactant. In some other embodiments, the solid compositions produce a non-soapy aqueous solution containing chlorine dioxide. These solid compositions comprise an alkali chlorite salt and a solid acid source.
    Type: Application
    Filed: September 12, 2007
    Publication date: March 20, 2008
    Applicant: SIPKA INC.
    Inventors: John Thangaraj, Lakkaraju Dasaradhi